Search

everythinglearnresearchcommunity

for

Search:↓

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Aromatase gene variation may increase female hair loss risk.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Spironolactone helps regrow hair in women with hair loss.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Men with Kennedy disease have less chance of hair loss.

Common acne treatments can cause various side effects, like skin irritation and more serious issues, but combination therapies are often more effective and better tolerated.

Hair loss affects quality of life, self-esteem, and confidence, but younger patients cope better.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Hair loss from genetics and hormones can be treated with drugs or surgery.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

Steroids are the best treatment for Alopecia Areata with few side effects.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

No link found between specific genes and female pattern hair loss.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Spironolactone effectively treats female pattern hair loss with few side effects.